Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.

Kim Y, Hong HH, Lachat Y, Clayton NP, Devereux TR, Melnick RL, Hegi ME, Sills RC.

Toxicol Pathol. 2005;33(3):307-12.

PMID:
15814359
2.

Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.

Goodrow T, Reynolds S, Maronpot R, Anderson M.

Cancer Res. 1990 Aug 1;50(15):4818-23.

4.

Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice.

Hegi ME, Söderkvist P, Foley JF, Schoonhoven R, Swenberg JA, Kari F, Maronpot R, Anderson MW, Wiseman RW.

Carcinogenesis. 1993 May;14(5):803-10.

PMID:
8504472
5.

Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.

Devereux TR, Foley JF, Maronpot RR, Kari F, Anderson MW.

Carcinogenesis. 1993 May;14(5):795-801.

PMID:
8504471
6.

Both K-ras and H-ras protooncogene mutations are associated with Harderian gland tumorigenesis in B6C3F1 mice exposed to isoprene for 26 weeks.

Hong HL, Devereux TR, Melnick RL, Eldridge SR, Greenwell A, Haseman J, Boorman GA, Sills RC.

Carcinogenesis. 1997 Apr;18(4):783-9.

PMID:
9111215
7.

Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years.

Hong HL, Ton TV, Devereux TR, Moomaw C, Clayton N, Chan P, Dunnick JK, Sills RC.

Toxicol Appl Pharmacol. 2003 Sep 15;191(3):227-34.

PMID:
13678655
8.
9.

Glial tumors in the MNU rat model: induction of pure and mixed gliomas that do not require typical missense mutations of p53.

Rushing EJ, Watson ML, Schold SC, Land KJ, Kokkinakis DM.

J Neuropathol Exp Neurol. 1998 Nov;57(11):1053-60.

PMID:
9825942
10.

Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.

Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M.

J Neuropathol Exp Neurol. 2007 Oct;66(10):944-54.

PMID:
17917588
11.

p53 mutations and microsatellite analysis of loss of heterozygosity in malignant gliomas.

Tenan M, Colombo BM, Pollo B, Cajola L, Broggi G, Finocchiaro G.

Cancer Genet Cytogenet. 1994 Jun;74(2):139-43.

PMID:
8019958
12.

Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.

Wang Y, Zhang Z, Lubet R, You M.

Oncogene. 2005 Apr 21;24(18):3042-9.

PMID:
15846305
13.

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

Alaminos M, Dávalos V, Ropero S, Setién F, Paz MF, Herranz M, Fraga MF, Mora J, Cheung NK, Gerald WL, Esteller M.

Cancer Res. 2005 Apr 1;65(7):2565-71.

14.

o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis.

Sills RC, Hong HL, Flake G, Moomaw C, Clayton N, Boorman GA, Dunnick J, Devereux TR.

Carcinogenesis. 2004 Apr;25(4):605-12. Epub 2003 Dec 19.

PMID:
14688030
15.

Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.

Pollack IF, Hamilton RL, James CD, Finkelstein SD, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL; Children's Oncology Group.

J Neurosurg. 2006 Nov;105(5 Suppl):418-24.

PMID:
17328268
16.

Evaluation of genetic alterations in cancer-related genes in lung and brain tumors from B6C3F1 mice exposed to 1,3-butadiene or chloroprene.

Ton TV, Hong HH, Devereux TR, Melnick RL, Sills RC, Kim Y.

Chem Biol Interact. 2007 Mar 20;166(1-3):112-20. Epub 2006 May 2.

PMID:
16860786
17.

Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens.

Louis DN, Rubio MP, Correa KM, Gusella JF, von Deimling A.

J Neuropathol Exp Neurol. 1993 Sep;52(5):507-15.

PMID:
8103086
18.

Alterations in tumour suppressor gene p53 in human gliomas from Indian patients.

Phatak P, Selvi SK, Divya T, Hegde AS, Hegde S, Somasundaram K.

J Biosci. 2002 Dec;27(7):673-8.

19.

PTEN gene mutations are seen in high-grade but not in low-grade gliomas.

Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH.

Cancer Res. 1997 Oct 1;57(19):4187-90.

20.

Absence of p53 autoantibodies in sera from glioma patients.

Rainov NG, Dobberstein KU, Fittkau M, Bahn H, Holzhausen HJ, Gantchev L, Burkert W.

Clin Cancer Res. 1995 Jul;1(7):775-81.

Supplemental Content

Support Center